Mike Sherman, the chief financial officer at West Lafayette-based Endocyte Inc., talked about how the drug firm’s funding partnership with New Jersey-based Merck & Co. Inc. has helped accelerate development of the company’s pipeline, which is branching out into drugs to treat cancers of the lung, prostate and breast.
A fellow conservative provided some support for Gov. Mike Pence’s claim that an expansion of Medicaid will become a “baby elephant” that eats up larger and larger shares of state resources.
One explanation for Indiana University Health’s decision to delay its Methodist Hospital expansion is that new “value-based” payment models appear to be pushing down hospitalization rates, according to a study released Friday.
Citing concerns about the economy and federal health reform, Indiana University Health has pressed pause on its plans to build a bed tower at Methodist Hospital that could have cost it as much as $500 million.
Eli Lilly and Co. and five other big drugmakers avoided paying $7 billion in U.S. taxes last year by shifting their profits overseas. The strategy has drawn the ire of some legislators.
Warsaw-based DePuy was accused of knowingly marketing a faulty implant that was later recalled.
Lawmakers are finding it difficult to write a law that effectively cracks down on the sale of synthetic drugs while remaining fair to businesses that might not know they’re on their shelves.
Local officials from around Indiana are making a push for the Legislature to require that people obtain a doctor's prescription to buy cold medications often used to make methamphetamine.
The proposal, which passed the Senate last month, is aimed at preventing the medicines from getting into the hands of people making methamphetamine.
While rural hospitals face sharp reductions in their operating incomes, most of the four major hospital systems based in Indianapolis will see only a marginal impact on their finances.
Trucking and auto fleet insurer Baldwin & Lyons Inc. plans to move its headquarters from downtown Indianapolis to Carmel by the end of the year and hopes to add 133 jobs over the next five years, the company announced Monday afternoon.
The Indiana Senate voted unanimously last week to require the Indiana Medicaid program to pay home health agencies, rural health clinics and federally qualified health centers for doing medical consultations, diagnoses and monitoring using videoconferencing, telephones or computers.
Eli Lilly and Co. has sued Roche Holding AG’s Genentech unit, asking a court to invalidate patents used to make treatments for cancer and autoimmune diseases.
The sequestration plan kicking in Friday will chop Medicare payments to hospitals, doctors and nursing homes by 2 percent, beginning April 1. One study estimates that the cuts could result in 10,000-plus job losses in Indiana alone.
The five-year trend of physician practices marrying up with hospitals has made it harder and harder for independent physician practices to spend time in more than one hospital system.
The Indiana Senate voted Tuesday to expand Medicaid using a state-run program, as lawmakers and Gov. Mike Pence continue negotiating how the state should cover an estimated 400,000 low-income residents.
Endocyte Inc. saw its shares fall nearly 7 percent Tuesday morning after the drug development firm announced that its application for U.S. approval of a cancer drug could be delayed another 10 months.
What are Zeke Turner's top five strategies for keeping his work week under 40 hours? Do you really need work e-mail on your smart phone? What's it like to take a company public? The real estate exec has answers.
The actuarial firm hired by the state estimates savings of about $156 million per year if Indiana uses its Healthy Indiana Plan to expand Medicaid coverage.
Between the new Marian college of medicine and an enrollment expansion at the Indiana University School of Medicine, the state will have 88 percent more med students by next fall.
